News

BLÜHEN BOTANICALS SET FOR GLOBAL EXPANSION FOLLOWING SIGNIFICANT INVESTMENT FROM CANNABIS INDUSTRY LEADER

Avatar
Written by Shared Content

TENNESSEE HEMP COMPANY TO LAUNCH PRODUCTS AND OPEN RETAIL LOCATIONS IN 2019

KNOXVILLE, Tenn. – February 25, 2019 – Blühen Botanicals, a Tennessee-based hemp cannabidiol (CBD) company, announced today that international cannabis business SOL Global Investments Corp. (CSE: SOL) (Frankfurt: 9SB) (OTCQB: SOLCF) is making a $30.6 million investment in Blühen as part of its plan to diversify into hemp-related businesses through HeavenlyRx Holdings.

The investment gives the Knoxville-headquartered company the financial and organizational platform to pursue its product rollout strategy across the United States and around the world. Market research firm Brightfield Group predicts that the CBD industry will be worth $22 billion by 2022.

“This investment from SOL Global, one of the biggest players in the global cannabis and hemp ecosystem, gives us the firepower to accelerate our growth strategy, and take advantage of the significant opportunities we see right now in the United States and around the world,” said Joe Fox, Blühen Botanicals’ Co-Founder and CEO. “The SOL Global team sees Blühen as a critical element in their aggressive CBD market expansion plans. Their investment in our vision provides us the confidence and capital to empower our success and longevity.”

“SOL Global’s investment enables us to exponentially scale our existing high-throughput capabilities while maintaining our commitment to providing the highest quality, pharmaceutical grade products on the market,” added Fox. “We have the largest network of expert farmers in the state of Tennessee who are growing hemp organically, and now, we’re empowered to scale our existing facilities faster, expand our farming network wider, and implement the highest international regulatory standards across the board.”

“This partnership will make Blühen the exclusive supplier of bulk extracts to HeavenlyRx,” said Brady Cobb, CEO of SOL Global Investments. “CBD is the primary cannabinoid available in North America, but there are more than 100 cannabinoids that will soon enter the market. This partnership will allow Blühen and HeavenlyRx to scale globally.”

Blühen’s commitment to scalable and diverse distribution springs from early strategic partnerships across the hemp industry’s growing supply chain. The uses of hemp CBD for pain, anxiety, and overall wellness have created a growing demand for the hemp crop. “Our goal is to produce the most premium and wellness-focused hemp CBD products, from seed to consumer,” said Erich Maelzer, Director of Horticulture/Co-Founder of Blühen. “Our products are based on scientific research performed in our dedicated R&D facility and in the hemp fields of local farmers growing hemp using Blühen guidelines.”

The vertically-integrated company employs farming advisors who work directly with hemp farmers to meet Blühen’s premium standards. The company also employs expert entomologists, plant pathologists, agronomists, chemists, and engineers on the 30-person team. The investment from SOL Global will enable Blühen to invest further in expanding its team and capabilities over the coming months

The next growth phase of the company includes opening wellness-focused retail locations throughout the country, beginning with its 4,086 sq. ft. flagship store in its hometown of Knoxville, Tenn. The retail store will be Blühen Botanicals’ fifth operation in Knoxville. Blühen’s boutique wellness products will be available for purchase in the Knoxville store and on the company’s website on May 17. Blühen’s next retail location will be in Fort Lauderdale, Fla. later this year.

As part of Blühen’s strategy to build a vertically-integrated supply chain, the company has also entered into agreements to purchase farmland in multiple states in addition to its partnerships with hemp farmers throughout the U.S.

About Blühen Botanicals

Headquartered in Knoxville, Tennessee, Blühen Botanicals is a hemp biomass processing and extraction company with farming and distribution partners across the United States. With a dedicated, pharmaceutical grade hemp research facility, Blühen works with manufacturers to produce custom formulations for its own blend of boutique wellness products such as full spectrum hemp extract tinctures, capsules, creams, and pet treats and oils. The company employs expert entomologists, plant pathologists, agronomists, chemists, and engineers on the 30-person team. The company will open its flagship retail location in Knoxville, Tenn. in May 2019 and plans to open a second retail location in Fort Lauder-dale, Fla. later this year. Learn more at www.bluhenbotanicals.com.

About SOL Global Investments Corp.

SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future front runner in the United States’ medical cannabis industry.

About the author

Avatar

Shared Content

Leave a Comment